While much of the US's attention has been on the Pfizer and Moderna vaccines, back in the spring of 2021, attention turned briefly to the Oxford/AstraZeneca COVID-19 vaccine when numerous countries halted its use due to concerns about blood clots. Now, ICAN has obtained exclusive confidential Periodic Safety Update Reports (PSURs) from the UK's FDA equivalent that shed light on numerous safety concerns. Lead Counsel, Aaron Siri, Esq. details the new information here: To date, approximately 2.4 billion doses of the AstraZeneca COVID-19 injection have been administered worldwide, including, infamously, in Europe. As the vaccine was rolled out, the UK's version of the FDA, the Medicines and Healthcare Regulatory Agency, was receiving confidential safety reports from AstraZeneca twice per year. While later PSURs have been released, the earliest ones were withheld from public view. Through FOIA requests, ICAN's attorneys have obtained these reports for December 2020–June 2021 and June 2021–December 2021.